Literature DB >> 28220463

Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?

Alfredo E Rodriguez1, Carlos Fernandez-Pereira2, Juan Mieres2, Javier Mendoza2, Florencia Sartori2.   

Abstract

PURPOSE OF REVIEW: In spite of the benefits of drug eluting (DES), these advantages were not translated to better outcome when percutaneous coronary interventions (PCI) were compared with coronary artery bypass surgery. PCI strategy allowing stent deployment in all intermediate lesions including small vessels together with DES design may be the reasons of these findings. RECENT
FINDINGS: Recently randomized and observational studies demonstrated using functional flow reserve analysis, residual Syntax score risk, or residual ERACI score after PCI that a reasonably incomplete revascularization was associated with good long-term outcome and low events rate at follow-up. In the ERACI IV study, which included patients with multiple vessel disease and left main, all intermediate lesions and severe lesions in small vessels were excluded from the revascularization strategy, and the 3-year follow-up results showed a remarkable low incidence of death/MI and stroke. Intermediate stenosis or severe lesions in small vessels should not be incorporated in the PCI strategy in order to define patient clinical cardiac prognosis or completeness of revascularization.

Entities:  

Keywords:  Completeness of revascularization; Coronary artery bypass surgery; Drug eluting stents; Multiple vessels disease; Randomized clinical trials; SYNTAX score; Stent thrombosis

Mesh:

Year:  2017        PMID: 28220463     DOI: 10.1007/s11886-017-0833-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  36 in total

1.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

2.  Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.

Authors:  Mohammad Alidoosti; Sepideh Saroukhani; Masoumeh Lotfi-Tokaldany; Arash Jalali; Amir Sobh-Rakhshankhah
Journal:  Cardiovasc Revasc Med       Date:  2016-03-28

Review 3.  Second versus first generation DES in multiple vessel disease and unprotected left main stenosis: insights from ERACI IV Study.

Authors:  A E Rodriguez
Journal:  Minerva Cardioangiol       Date:  2015-03-17       Impact factor: 1.347

4.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

5.  Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Authors:  Akhil Kapur; Roger J Hall; Iqbal S Malik; Ayesha C Qureshi; Jeremy Butts; Mark de Belder; Andreas Baumbach; Gianni Angelini; Adam de Belder; Keith G Oldroyd; Marcus Flather; Michael Roughton; Petros Nihoyannopoulos; Jens Peder Bagger; Kenneth Morgan; Kevin J Beatt
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 24.094

6.  Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.

Authors:  Philippe Généreux; Carlos M Campos; Vasim Farooq; Christos V Bourantas; Friedrich W Mohr; Antonio Colombo; Marie-Angèle Morel; Ted E Feldman; David R Holmes; Michael J Mack; Marie-Claude Morice; A Pieter Kappetein; Tullio Palmerini; Gregg W Stone; Patrick W Serruys
Journal:  Am J Cardiol       Date:  2015-04-23       Impact factor: 2.778

7.  The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.

Authors:  Guy Witberg; Ifat Lavi; Abid Assali; Hana Vaknin-Assa; Eli Lev; Ran Kornowski
Journal:  Catheter Cardiovasc Interv       Date:  2015-04-09       Impact factor: 2.692

8.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.

Authors: 
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

9.  Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.

Authors:  Mineok Chang; Jung-Min Ahn; Cheol Whan Lee; Rafael Cavalcante; Yohei Sotomi; Yoshinobu Onuma; Erhan Tenekecioglu; Minkyu Han; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Seong-Wook Park; Patrick W Serruys; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2016-07-05       Impact factor: 24.094

10.  Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.

Authors:  Philippe Généreux; Carlos M Campos; Mayank Yadav; Tullio Palmerini; Adriano Caixeta; Ke Xu; Dominic P Francese; George D Dangas; Roxana Mehran; Martin B Leon; Patrick W Serruys; Gregg W Stone
Journal:  EuroIntervention       Date:  2015-10       Impact factor: 6.534

View more
  3 in total

Review 1.  Fallacies and Possible Remedies of the SYNTAX Score.

Authors:  Yong-Ming He; Li Shen; Jun-Bo Ge
Journal:  J Interv Cardiol       Date:  2020-12-15       Impact factor: 2.279

2.  Relationship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Altekin Refik Emre; Kilinc Ali Yasar; Yanikoglu Atakan; Cicekcibasi Orhan; Kucuk Murathan
Journal:  Cardiovasc Ther       Date:  2020-08-13       Impact factor: 3.023

3.  Prognostic Value of the Residual SYNTAX Score on In-Hospital and Follow-Up Clinical Outcomes in ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Refik Emre Altekin; Ali Yasar Kilinc; Mehdi Onac; Orhan Cicekcibasi
Journal:  Cardiol Res Pract       Date:  2020-10-29       Impact factor: 1.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.